What Happened?
cambridge, MA-based QurAlis Appointed Kasper Roet as Founder, Chief Executive Officer
About the Company
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. We are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus our programs on tackling specific disease-causing mechanisms.
About the Person
Kasper Roet is Founder, Chief Executive Officer at QurAlis. Previously, Kasper held various senior HR leadership roles in the industry.
Info Source
News
Short Profile